Autonomix Medical
(NASDAQ) AMIX
Autonomix Medical Financials at a Glance
Market Cap
$3.67MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$16.72M
EPS (TTM)
-$64.03
P/E Ratio
-0.11
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$6.56
Volume
0
Open
$6.43
Price
$6.56
Volume
0
Open
$6.43
Previous Close
$6.56
Daily Range
$6.36 - $6.56
52-Week Range
$4.20 - $55.44
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$6.56
Volume
0
Open
$6.43
Previous Close
$6.56
Daily Range
$6.36 - $6.56
52-Week Range
$4.20 - $55.44
Estimated Earnings Date
Aug 12, 2026
AMIX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Autonomix Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
11
CEO
Bradley A. Hauser
Website
autonomix.comHeadquarters
The Woodlands, TX 77380, US
AMIX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-239.36%
Return on Capital
-288.96%
Return on Assets
-219.93%
Earnings Yield
-9.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.67MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
543.30K
Volume
0
Avg. Volume
38.26K
Financials (TTM)
Gross Profit
-$3.00K
Operating Income
-$17.04M
EBITDA
-$16.77M
Operating Cash Flow
-$11.13M
Capital Expenditure
-$10.00K
Free Cash Flow
-$11.14M
Cash & ST Invst.
$7.00M
Total Debt
$0.00
Autonomix Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$3.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$3.67MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$367.27K
N/A
Employees
10
N/A
Net Income
-$2.67M
+16.5%
EBITDA
-$2.73M
+11.7%
Quarterly Fundamentals
Total Cash
$7.00M
-23.3%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-2.20%
N/A
Return on Invested Capital
-2.89%
N/A
Free Cash Flow
-$2.90M
-15.2%
Operating Cash Flow
-$2.89M
-15.3%